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Abstract 
Objective: To evaluate the prevalence and the clinical characteristics of wheezing in 
infants aged 12 to 15 months in the city of Cuiabá, Mato Grosso State, Midwest Brazil. 
Methods: Parents and/or guardians of infants were interviewed and completed a written 
standardized questionnaire of the Estudio Internacional de Sibilancia en Lactantes (EISL) 
– phase 3 at primary healthcare clinics at the same day of children vaccination or at 
home, from August of 2009 to November of 2010. 
Results: 1,060 parents and/or guardians completed the questionnaire, and 514 (48.5%) 
infants were male. Among the studied infants, 294 (27.7%) had at least one episode 
of wheezing during the first year of life, beggining at 5.8±3.0 months of age, with a 
predominance of male patients. The prevalence of occasional wheezing (<3 episodes of 
wheezing) was 15.0% and recurrent wheezing (≥3 episodes) was 12.7%. Among the infants 
with recurrent wheezing, the use of inhaled β2-agonist, oral corticosteroid, leukotriene 
receptor antagonist, as well as night symptoms, respiratory distress, and hospitalization 
due to severe episodes were significantly more frequent. Physician-diagnosed asthma 
was observed in 28 (9.5%) of the wheezing infants. Among the wheezing infants, 80 
(27.7%) were diagnosed with pneumonia, of whom 33 (11.2%) required hospitalization; 
neverthless, no differences between occasional and recurrent wheezing infants were 
found. 
Conclusions: The prevalence of recurrent wheezing and physician-diagnosed asthma in 
infants were lower compared with those observed in other Brazilian studies. Recurrent 
wheezing had early onset and high morbity.
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
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Introduction
Wheezing is one of the most common respiratory symptoms 
in childhood and can manifest in several respiratory 
diseases; asthma is the most common. It is estimated that 
approximately 50% to 80% of children with asthma develop 
symptoms in the first five years of life, but diagnosis is 
difficult in this age group due to the difficulties in performing 
pulmonary function tests and the high prevalence of other 
causes of wheezing.1 
Despite the significant impact of recurrent wheezing 
in childhood on public health, especially in developing 
countries, until recently there was no international 
comparative information on the prevalence of wheezing 
obtained by a standardized and validated tool, especially 
in the first year of life, when children are more vulnerable 
to complications from anatomical, functional, and 
immunological characteristics of the airways.2
To assess the impact of recurrent wheezing in infants in the 
first year of life and determine its prevalence and associated 
risk factors, the international study Estudio Internacional 
de Sibilancias en Lactantes (EISL) was developed. This is an 
international multicenter study comprising Latin America 
countries, Spain, and the Netherlands.3
The first data obtained in Brazil with the EISL were from 
3,003 infants in the city of Curitiba, PR; it was observed 
that, in the first 12 months of life, 45.4% had at least one 
episode and 22.6% had recurrent wheezing episodes (three 
or more), evidencing a high prevalence of wheezing, with 
early onset and high morbidity.4 In São Paulo, SP, Brazil, in 
1,014 infants living in the central-south region, 46% had at 
least one episode and 26.6% recurrent wheezing episodes. 
Also in São Paulo, the onset of wheezing was early, around 
five months of life, and the proportion of infants diagnosed 
and treated as asthmatics was low, which demonstrates 
the difficulty of attaining physician-diagnosed asthma in 
this age group.5
The prevalence of at least one episode of wheezing in 
the first year of life was 61% of infants residing in the city 
of Porto Alegre, RS, Brazil6 and 43% of infants in the city of 
Recife, PE, Brazil.7 
The data obtained at the first phase of the study 
conducted in Latin America and Europe found that, of 
30,093 infants, 45.2% had at least one episode and 20.3% 
had recurrent wheezing episodes, with a mean prevalence 
of recurrent wheezing in Latin American countries of 
21.4%, while in European countries it was 15%. There was 
significant morbidity associated with recurrent wheezing 
in terms of severe episodes, visits to emergency rooms, 
hospital admissions, and use of inhaled corticosteroids.8
Considering that wheezing in infants is a very common 
symptom, whose prevalence varies in different centers, that 
the causes for such variations are still under investigation, 
and that Brazil is a country with a large territory with 
climatic, cultural, and socioeconomic differences, this 
study aimed to determine the prevalence and clinical 
characteristics of wheezing in infants living in Cuiabá, MT, 
using the standardized tool EISL – phase 3.
Prevalência e características clínicas da sibilância em crianças no primeiro ano de 
vida, residentes na cidade de Cuiabá, Mato Grosso, Brasil
resumo 
Objetivo: Determinar a prevalência e as características clínicas da sibilância em lactentes 
(12-15 meses) residentes em Cuiabá (MT). 
Métodos: Pais e/ou responsáveis pela criança foram entrevistados e responderam ao 
questionário escrito padronizado do “Estudio Internacional de Sibilancia en Lactantes” 
(EISL) – fase 3, em unidades básicas de saúde por ocasião da vacinação de rotina ou 
durante visitas nos domicílios de crianças matriculadas nos programas de saúde da 
família no período de agosto de 2009 a novembro de 2010.
Resultados: 1060 pais e/ou responsáveis responderam ao questionário escrito, sendo 514 
(48,5%) lactentes do sexo masculino. Dos lactentes, 294 (27,7%) tiveram pelo menos um 
episódio de sibilância no primeiro ano de vida, com início aos 5,8±3,0 meses e predomínio 
em meninos. A prevalência de sibilância ocasional (<3 episódios de sibilância) foi 15% 
e a recorrente (≥3 episódios) foi 12,7%. Entre estes, o uso de broncodilatador inalado, 
corticosteroide oral, antileucotrieno, presença de sintomas noturnos, dificuldade para 
respirar e internação por sibilância foram significantemente mais frequentes. Diagnóstico 
médico de asma foi evidenciado em 28 (9,5%) dos lactentes sibilantes. Dos lactentes 
sibilantes, 80 (27,7%) relataram ocorrência prévia de pneumonia, sendo que 33 (11,2%) 
necessitaram internação para tratamento, porém não houve diferença entre os grupos 
de sibilantes. 
Conclusão: A prevalência de sibilância recorrente em lactentes foi mais baixa em 
comparação a outros estudos brasileiros, assim como o diagnóstico médico de asma. 
Sibilância recorrente teve início precoce e alta morbidade.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Method
Parents or guardians of infants aged between 12 and 15 
months living in the city of Cuiabá, state of Mato Grosso, 
Brazil, and who answered the standard EISL written 
questionnaire (WQ-EISL) – Phase 3 participated in this study. 
Parents and/or guardians were invited to participate in the 
study when upon seeking the Basic Health Units (BHU) for 
consultations and/or routine vaccination of their children 
or through home visits to children enrolled in the Family 
Health Program of the BHUs. This visit was conducted 
together with health care providers to facilitate access to 
households.
At the time when study was performed, there were 60 
BHUs distributed in four regions (North, South, East, and 
West). In the North, West, and East regions, population 
density is medium-high: 57.4 to 86.0 inhabitants/hectare 
(inhab/ha); in the south region, population density is 
medium-low (11.05 to 28.76 inhab/ha).
Twenty-eight BHUs were selected by drawing lots to 
apply the written questionnaires, with six units in the 
North, West, and East regions and ten units in the South 
region, due to the lower population density. Visits to the 
BHUs occurred between August of 2009 and November of 
2010 and during the two immunization campaigns against 
childhood polio conducted during this period; all children 
of the desired age group who came to the BHU on the day 
of the campaign participated in the study. Parents and/or 
guardians signed an informed consent form (ICF) and were 
then interviewed by the main researcher or by a previously 
trained medical student from Universidade Federal do Mato 
Grosso (UFMT).
The WQ-EISL phase 3 consists of 50 questions on 
demographic characteristics, wheezing, and risk factors; 
it has been translated into Brazilian Portuguese and 
culturally validated.9 For that study, it was determined by 
the coordinators of the EISL that the sample should include 
at least 1,000 infants. This sample size was based on the 
International Study of Asthma and Allergies in Childhood 
(ISAAC), considering a prevalence of wheezing of 30% 
and 25% in two different centers, with a power of study 
of 95% and a significance level of 1% for this sample, to 
ensure adequate power for comparisons between centers 
and countries, even for questions with a low prevalence of 
positive answers.3,10
Data were encoded in a standardized manner, transferred 
to a database developed in Microsoft Excel® 2007, and 
statistically analyzed using SPSS for Windows – release 18.0. 
Wheezing infants were separated into groups taking into 
account the frequency of wheezing: less than three episodes 
of wheezing (occasional wheezing) and three or more 
episodes of wheezing (recurrent wheezing). Those who had 
never had wheezing episodes were called non-wheezers. 
To analyze variable dependence, parametric (Student’s 
t-test) and nonparametric (chi-squared and Fisher’s exact 
test) tests were employed, as well as logistic regression for 
joint analysis of the possible factors related to the severity 
of recurrent wheezing. The significance level was set at 
0.05 for the rejection of the null hypothesis.
This study was approved by the Research Ethics Committee 
of the Universidade Federal de São Paulo/Escola Paulista 
de Medicina – UNIFESP/EPM and by the Research Ethics 
Committee of the Hospital Universitário Júlio Müller/UFMT 
in Cuiabá-MT.
results
A total of 1,060 parents and/or guardians of infants 
aged between 12 and 15 months were interviewed. No 
questionnaire was excluded from the sample for being 
incorrectly filled out. Most respondents were mothers 
(87.9%), followed by other relatives (6.4%), and fathers 
(5.7%). Of the 1,060 children, 546 were females (51.5%). 
The general characteristics of the study population are 
shown in Table 1.
Of the assessed infants, 294 (27.7%) had at least one 
episode of wheezing in the first year of life (wheezers), 
with wheezing onset at 5.8±3.0 months. The population 
of wheezing and non-wheezing infants was homogeneous 
regarding weight and length at birth and at 12 months, 
but there was a prevalence of wheezing episodes in males 
(Table 1). The prevalence of occasional wheezing was 
15.0%, and of recurrent wheezing, 12.7%.
Table 2 presents the clinical characteristics of wheezing 
infants in relation to gender. It was observed that the use 
Table 1 General characteristics of the study population (n=1,060).
Variables Wheezers n=294  Non-wheezers n=766  p
 n Results n Results
Gendera  
 Male 159 31% 355 69% 0,03 
 Female 135 25% 411 75%
Birth weight (kg)b 291 3.1±0.5 761 3.2±0.5 0.18
Current weight (kg)b 276 10.2±1.5 738 10.1±1.4 0.73
Birth length (cm)b 276 48.6±2.6 710 48.7±2.3 0.46
Current length (cm)b 178 76.0±4.7 466 76.2±4.2 0.71
Children’s age (months)b 294 13.3±1.2 766 13.2±1.2 0.71
Age at the start of wheezing (months) 294 5.8±3.3 766 — —
a Fisher’s exact test or chi-squared test; b Student’s t-test (mean±standard deviation)
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of anti-leukotrienes in the treatment of wheezing, as well 
as the occurrence of nocturnal awakenings, were more 
common in male infants. The use of oral corticosteroids 
was common, but without significant differences between 
the genders. 
A medical diagnosis of asthma was observed in 28 (9.5%) 
infants. Of the wheezing infants, 80 (27.7%) were diagnosed 
with pneumonia and 33 (11.2%) required hospitalization 
for treatment, but there were no differences regarding 
gender.
Table 3 presents the clinical characteristics of the infants 
according to the number of wheezing episodes. It was 
observed that the use of an inhaled bronchodilator, oral 
corticosteroids, and anti-leukotrienes; the perception of 
breathlessness by parents; frequent nocturnal awakening; 
hospitalization for wheezing; and medical diagnosis of 
asthma were more frequent in infants with recurrent 
wheezing. 
At the multivariate analysis, the variables that remained 
associated with recurrent wheezing were the use of anti-
leukotrienes (OR=4.1, 95% CI: 1.10 to 15.17) and the 
perception of breathlessness by parents (OR=2.9, 95% CI: 
1.84 to 4.85).
Discussion
The prevalence of occasional and recurrent wheezing in the 
first year of life in the city of Cuiabá was lower than those 
observed in other Brazilian studies, such as Curitiba, São 
Table 2 Clinical characteristics of infants with at least one wheezing episode in the first year of life according to gender 
(n=294).
Characteristics Male n=159  Female n=135 (%) Total n=294 (%) pa
Less than three wheezing episodes 84 (53%) 75 (56%) 159 (54%) 0.64
Three to six wheezing episodes 55 (35%) 38 (28%) 93 (32%) 0.24
Six or more wheezing episodes 20 (13%) 22 (16%) 42 (14%) 0.36
Use of inhaled beta-agonist  132 (84%) 101 (76%) 233 (80%) 0.08
Use of inhaled corticosteroid  39 (25%) 27 (20%) 66 (23%) 0.34
Use of oral corticosteroid  69 (44%) 48 (37%) 117 (41%) 0.23
Use of anti-leukotriene 11 (7%)a 2 (2%) 13 (5%) 0.02
Frequent nocturnal awakenings  20 (13%)a 6 (4%) 26 (9%) 0.01
Emergency room consultations 110 (69%) 79 (59%) 189 (64%) 0.06
Perception of breathlessness by parents 66 (42%) 50 (37%) 116 (40%) 0.43
Hospitalization due to wheezing 23 (15%) 19 (14%) 42 (14%) 0.92
Medical diagnosis of asthma 15 (9%) 13 (10%) 28 (10%) 0.95
Pneumonia 47 (30%) 33 (24.4) 80 (27%) 0.33
Hospitalization due to pneumonia 19 (12) 14 (10.4) 33 (11%) 0.67
aFisher’s exact test or chi-squared test
Table 3 Clinical characteristics of infants according to the number of wheezing episodes (occasional [less than three episodes 
of wheezing] and recurrent [three or more episodes of wheezing]) in the first year of life.
Variables  Wheezing in the first year of life
  Occasional n=159 Recurrent n=135 pa 
Gender Male 84 (53%) 75 (56%) 0.36 
 Female 75 (47%) 60 (44%)
Use of inhaled beta-agonistb 119 (75%) 114 (84%) 0.002
Use of inhaled corticosteroid  30 (19%) 36 (27%) 0.07
Use of oral corticosteroidb 53 (33%) 64 (47%) 0.009
Use of anti-leukotrieneb 3 (2%) 10 (7%) 0.020
Frequent nocturnal awakeningsb 7 (4%) 19 (14%) 0.003
Emergency room consultations 98 (62%) 91 (67%) 0.18
Perception of breathlessness by parentsb 44 (28%) 72 (53%) <0.001
Hospitalization due to wheezingb 15 (9%) 27 (20%) 0.008
Medical diagnosis of asthmab 8 (5%) 20 (15%) 0.004
Pneumonia  38 (24%) 42 (31%) 0.11
Hospitalization due to pneumonia 13 (8%) 20 (14.8) 0.050
a Fisher’s exact test or chi-squared test; b statistically significant values
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Paulo, Recife, and Porto Alegre,4-7 but similar to that found 
in European countries.8 The mean prevalence of recurrent 
wheezing in European countries is 15.0%, while in Latin 
America it is 21.4%.8 The variability that occurs in different 
countries or even within the same country suggests the 
influence of local environmental factors on the clinical 
expression of several wheezing phenotypes in childhood, 
reinforcing the need for more studies in Brazilian cities for 
better comparison, as this is a country with a large territory 
and climate, cultural, and socioeconomic differences. 
When comparing data from Cuiabá regarding the 
prevalence of wheezing in the first year of life and wheezing 
in the last 12 months in schoolchildren and adolescents,11,12 
a discrepancy was observed, as the values  are close to the 
observed mean national values.13 This finding suggests that 
asthma in Cuiabá may have a later onset in childhood; 
longitudinal studies are needed to better understand the 
different wheezing phenotypes in the first years of life and 
their association with the diagnosis of asthma in children 
and adolescents.
Wheezing was more common in male infants; this group 
showed a higher frequency of symptom severity, such as 
nocturnal awakenings and use of medications. Previous 
studies have shown that male gender is a risk factor for 
wheezing in childhood6,21 and the smaller airway-caliber in 
boys early in life is indicated as a possible explanation for 
this fact.14 
The use of oral corticosteroids by the study infants was 
high, similar to that observed in other Brazilian studies.5,7,15 
The use of this medication, as expected, was higher in the 
group of recurrent wheezing when compared to occasional 
wheezing, and was also higher than the use of inhaled 
corticosteroids. In a study of 118 infants followed-up 
for one year after the first wheezing episode, 37% had 
recurrent wheezing, even when treated with prednisolone 
for a short period of time. The risk for recurrent wheezing 
among those receiving placebo was five-fold higher in those 
with rhinovirus infection than in those with infection by 
respiratory syncytial virus (RSV). 
Among those who used prednisolone and had rhinovirus 
infection, there was a reduction in recurrent wheezing, a 
fact that was not observed in those with RSV infection. This 
evidences that, if there are benefits in the use of systemic 
corticosteroids in infants with wheezing associated with 
viral respiratory infections, such benefits must be related 
to a concomitant allergic disease.16 However, in preschool 
children with moderate virus-induced wheezing seeking 
emergency services, prednisolone was administered 
for five days aiming to verify its clinical efficacy using 
a symptom score, length of hospital stay, and symptom 
persistence. 
It was observed that there was no significant difference 
with the use of prednisolone in preschool children with virus-
induced wheezing in relation to time of hospitalization and 
symptom score, even in those who had a positive asthma 
predictive index (API).17 If infants are excessively treated 
with oral corticosteroids, this can be explained by the fact 
that some centers in Brazil provide asthma medications 
through the public health network or because the guidelines 
for asthma management are not known or are inadequately 
followed.18 In Cuiabá, there is no public health program 
to monitor these children and parents preferentially seek 
emergency units, which could explain the large consumption 
of this type of medication in wheezing exacerbations to the 
detriment of preventive treatment for recurrence.
The use of anti-leukotrienes was also more frequent in 
the group of recurrent wheezing. International guidelines 
have recommended anti-leukotrienes for recurrent 
wheezing control therapy as an alternative to the use of 
inhaled corticosteroids, mainly in infants and preschool 
children with virus-induced wheezing.19,20 However, only 
4.5% of wheezing infants used them in the study, which 
may be related to their high cost and the fact that they are 
not available in the public health system.
Regarding the demand for emergency services by parents, 
the prevalence was high (64.3%), although the rate of 
hospitalization for wheezing was only 14.3%, and the latter 
was more frequent among recurrent wheezers (OR=2.4, 95% 
CI: 1.22 to 4.73). The high demand for emergency services 
can be explained by symptom worsening in the presence 
of airway infections, most often of viral origin; conversely, 
it may be due to the fact that these emergency services 
are being misused as consultation sites due to failure of 
the primary care network in monitoring these children with 
recurrent wheezing.
The rate of medical diagnosis of asthma was low (9.5%), 
but was more frequent in the group of recurrent wheezing, 
a finding that is in agreement with other Brazilian studies.4,5 
The diagnosis of asthma in this age group is very difficult, 
given the many wheezing phenotypes. The study of these 
phenotypes is extremely important to identify children 
with recurrent wheezing, which will have a higher risk for 
developing asthma over the years.21 In a prospective study, 
it was observed that most children who had wheezing 
in childhood had early episodes in the first year of life. 
Of these, half persisted with wheezing at age 6 years, 
being considered asthmatic.22 Thus, the challenge is to 
differentiate, among the wheezing infants, those who will 
persist with episodes (probable asthma)  from those who 
are just transient wheezers.
In Brazil, the term “asthma” is often replaced by the 
term “bronchitis” when it comes to asthma in children, 
introducing an additional bias in epidemiological 
investigations.23 Even in studies that assessed the 
prevalence of wheezing in the past 12 months in older 
children (6-7 years) and adolescents (13-14 years) in two 
cities of Mato Grosso, the medical diagnosis of asthma was 
also low: 8.4% in Cuiabá and 6% in Alta Floresta.12-24 Due to 
all these factors, it can be concluded that it is difficult for 
physicians to differentiate between asthma in infants and 
recurrent wheezing disease. 
The report of pneumonia was observed in 27.2% of 
wheezing infants, with low hospitalization rate (11.2%) 
and no significant difference between the wheezing 
groups. In another study, both the diagnosis of pneumonia 
and hospitalization for pneumonia were associated with 
recurrent wheezing.5
This difference can be explained, in part, by the lower 
prevalence of recurrent wheezing in Cuiabá, when compared 
to other Brazilian studies. 
Regarding the lower airway infections caused by 
bacteria, such as pneumonia, it is not known whether their 
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occurrence in the first years of life could be associated 
with asthma development. A recent publication showed 
that radiologically-confirmed bacterial pneumonia was 
associated with increased risk of asthma or wheezing in 
preschool children.25 Another cohort study of newborns of 
low socioeconomic status in Santiago (Chile) followed-up 
during the first year of life observed a prevalence of 13.3% 
of pneumonia and indicated that the presence of recurrent 
wheezing during the first three months of life was strongly 
associated with the diagnosis of pneumonia.26 
The results of this investigation should be analyzed from 
a critical point of view, because, as all cross-sectional 
studies, it has some limitations. This study used parents’ 
reports rather than medical reports. Evaluation of wheezing 
in infants is difficult for parents and may be confused with 
sounds coming from upper airway secretions.27 However, 
the validation study of the EISL questionnaire assessed 
the agreement between parents’ reports and the findings 
of the physical examination performed by a physician, 
showing high agreement for most questions that employed 
the terms “wheezing”, “wheeziness”, and “bronchitis”, 
thus demonstrating that this questionnaire is valid and 
reproducible to obtain reliable data on wheezing in infants 
aged 12-36 months of life.28 
Moreover, the information about wheezing in the first 12 
months of life was obtained when the infants were 12 to 
15 months, thereby decreasing the likelihood of recall bias. 
Other important aspects of this study are the sample size 
and the implementation of a standardized questionnaire 
that allowed for the comparison between different centers 
that participated in the study. 
It can be concluded that the prevalence of wheezing in 
the first year of life in Cuiabá, MT, was not as high as in other 
Brazilian cities, but had early onset and high morbidity; 
however, the medical diagnosis of asthma was low. The 
authors emphasize the importance of implementing in 
Brazil a primary care program to monitor wheezing infants, 
aiming at the adequate management of the disease in order 
to reduce morbidity and improve quality of life of infants 
and their families.
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